Viewing StudyNCT01670500



Ignite Creation Date: 2024-05-06 @ 12:50 AM
Last Modification Date: 2024-10-26 @ 10:55 AM
Study NCT ID: NCT01670500
Status: COMPLETED
Last Update Posted: 2022-05-25
First Post: 2012-08-16

Brief Title: Cisplatin vs DoxorubicinCyclophosphamide in BrCa
Sponsor: Beth Israel Deaconess Medical Center
Organization: Dana-Farber Cancer Institute

Key Dates - Follows AllAPIJSON File Order

Start Date: 2012-10
Start Date Type: None
Primary Completion Date: 2019-05
Primary Completion Date Type: ACTUAL
Completion Date: 2023-04
Completion Date Type: ESTIMATED
First Submit Date: 2012-08-16
First Submit QC Date: August 20 2012
Study First Post Date: 2012-08-22
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2020-08-03
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-22
Last Update Post Date: 2022-05-25
Last Update Post Date Type: ACTUAL